O4 Comorbidity, age and performance status are important predictors of outcome in older multiple myeloma patients treated with melphalan and corticosteroids: subgroup analysis from the National Cancer Institute of Canada MY7 trial
Titel:
O4 Comorbidity, age and performance status are important predictors of outcome in older multiple myeloma patients treated with melphalan and corticosteroids: subgroup analysis from the National Cancer Institute of Canada MY7 trial
Auteur:
Kouroukis, C.T. Hafid, T. Wong, J. Kovacs, M.J. Barr, R. Findlay, B. Shepherd, L. Djurfeldt, M. Ding, K. Zhu, L. Shustik, C. Meyer, R.